So CW - Search Results

1

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.

Lam SS, Ho ES, He BL, Wong WW, Cher CY, Ng NK, Man CH, Gill H, Cheung AM, Ip HW, So CC, Tamburini J, So CW, Ho DN, Au CH, Chan TL, Ma ES, Liang R, Kwong YL, Leung AY. Lam SS, et al. Among authors: so cc, so cw. Sci Transl Med. 2016 Oct 5;8(359):359ra129. doi: 10.1126/scitranslmed.aaf3735. Sci Transl Med. 2016. PMID: 27708062 Clinical Trial.

2

SnapShot: Acute myeloid leukemia.

Zeisig BB, Kulasekararaj AG, Mufti GJ, So CW. Zeisig BB, et al. Among authors: so cw. Cancer Cell. 2012 Nov 13;22(5):698-698.e1. doi: 10.1016/j.ccr.2012.10.017. Cancer Cell. 2012. PMID: 23153541 Free article. No abstract available.

3

Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia.

He BL, Shi X, Man CH, Ma AC, Ekker SC, Chow HC, So CW, Choi WW, Zhang W, Zhang Y, Leung AY. He BL, et al. Among authors: so cw. Blood. 2014 Apr 17;123(16):2518-29. doi: 10.1182/blood-2013-02-486688. Epub 2014 Mar 3. Blood. 2014. PMID: 24591202 Free PMC article.

4

Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.

Man CH, Fung TK, Wan H, Cher CY, Fan A, Ng N, Ho C, Wan TS, Tanaka T, So CW, Kwong YL, Leung AY. Man CH, et al. Among authors: so cw. Blood. 2015 Jun 18;125(25):3928-36. doi: 10.1182/blood-2014-06-580993. Epub 2015 May 4. Blood. 2015. PMID: 25940713 Free article.

5

Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors.

Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, Gil J, Leung AY, Ashworth A, So CW. Esposito MT, et al. Among authors: so cw. Nat Med. 2015 Dec;21(12):1481-90. doi: 10.1038/nm.3993. Epub 2015 Nov 23. Nat Med. 2015. PMID: 26594843

6

PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment.

Zhao L, So CW. Zhao L, et al. Among authors: so cw. Exp Hematol. 2016 Oct;44(10):902-7. doi: 10.1016/j.exphem.2016.07.007. Epub 2016 Jul 26. Exp Hematol. 2016. PMID: 27473567 Free article. Review.

7

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.

He BL, Yang N, Man CH, Ng NK, Cher CY, Leung HC, Kan LL, Cheng BY, Lam SS, Wang ML, Zhang CX, Kwok H, Cheng G, Sharma R, Ma AC, So CW, Kwong YL, Leung AY. He BL, et al. Among authors: so cw. EMBO Mol Med. 2020 Apr 7;12(4):e10895. doi: 10.15252/emmm.201910895. Epub 2020 Mar 5. EMBO Mol Med. 2020. PMID: 32134197 Free PMC article.

8

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.

He BL, Yang N, Man CH, Ng NK, Cher CY, Leung HC, Kan LL, Cheng BY, Lam SS, Wang ML, Zhang CX, Kwok H, Cheng G, Sharma R, Ma AC, So CWE, Kwong YL, Leung AY. He BL, et al. EMBO Mol Med. 2020 Aug 7;12(8):e12911. doi: 10.15252/emmm.202012911. EMBO Mol Med. 2020. PMID: 32767634 Free PMC article.

9

Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia.

Zeisig BB, Fung TK, Zarowiecki M, Tsai CT, Luo H, Stanojevic B, Lynn C, Leung AYH, Zuna J, Zaliova M, Bornhauser M, von Bonin M, Lenhard B, Huang S, Mufti GJ, So CWE. Zeisig BB, et al. Sci Transl Med. 2021 Feb 24;13(582):eabc4822. doi: 10.1126/scitranslmed.abc4822. Sci Transl Med. 2021. PMID: 33627486

10

Therapeutic Opportunities of Targeting Canonical and Noncanonical PcG/TrxG Functions in Acute Myeloid Leukemia.

Zeisig BB, So CWE. Zeisig BB, et al. Annu Rev Genomics Hum Genet. 2021 Aug 31;22:103-125. doi: 10.1146/annurev-genom-111120-102443. Epub 2021 Apr 30. Annu Rev Genomics Hum Genet. 2021. PMID: 33929894 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page